about
Haloperidol dose for the acute phase of schizophreniaChlorpromazine versus placebo for schizophreniaChlorpromazine versus atypical antipsychotic drugs for schizophreniaHaloperidol versus placebo for schizophreniaPimozide for schizophrenia or related psychosesOpioid antagonists for alcohol dependenceAntipsychotic medication for early episode schizophreniaChlorpromazine dose for people with schizophreniaHaloperidol versus chlorpromazine for schizophreniaTestosterone for schizophreniaPimozide for schizophrenia or related psychosesThioridazine for schizophreniaRisperidone versus olanzapine for schizophreniaCessation of medication for people with schizophrenia already stable on chlorpromazineTrifluoperazine for schizophreniaNew generation antipsychotics for first episode schizophreniaCurrent approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatmentsDefinitions and drivers of relapse in patients with schizophrenia: a systematic literature reviewCost-effectiveness of pharmacological and psychosocial interventions for schizophrenia.Comparative effects of Rauwolfia vomitoria and chlorpromazine on social behaviour and pain.Dose equivalents for second-generation antipsychotics: the minimum effective dose method.Using the needs of WHO to prioritise Cochrane reviews: The case of antipsychotic drugs.Not at issueStandardising outcomes for clinical trials and systematic reviews.Haloperidol versus chlorpromazine for treatment of schizophrenia.Perspectives towards mental illness in people living with HIV/AIDS in South Africa.Standardising Outcomes in Paediatric Clinical Trials.
P2860
Q24200200-E2A2F8FF-B558-48B6-8155-366DF6431D97Q24201214-496C85EB-0F05-46C3-A65E-F88555FEFDF6Q24201691-26C724ED-D204-469C-A5AD-5B8DDEBEBC06Q24202457-D98D8AFB-0A12-4EC6-97B4-A75A83AD254FQ24202537-B9E9C999-02F7-4EEE-9D76-31560DEC1E12Q24235797-F3575C70-FD72-48EB-9203-3A4AE09DCFEAQ24236683-F87FF9DF-FF51-48A5-ABAA-00BDAE8E48C2Q24241655-F94C0FB2-5EC9-413A-8379-49D47190D419Q24242553-E88F6251-8A15-40F7-907F-B10168687757Q24243894-6BE12BDA-CD3E-43EE-B1B6-33F515C58149Q24244147-F741B8A9-9127-4123-B307-77B8893496E8Q24244320-E009731F-70C7-4D98-8983-C6CAD5EDC7B8Q24246232-2D9644EE-2C97-4F65-A481-032DA176A182Q24246474-29A1974F-B903-4A93-B626-D17BFEF6AA18Q24247440-F9D0B612-1B7A-4D80-819E-977716D93287Q24247720-67E5E32D-11B3-4183-A8E0-E91C37D680EDQ27003099-7D5C5771-23B8-4F4A-8396-C6F9FED0EBE2Q33589087-77FF3B83-55BD-4848-AF4B-1372781CCE42Q35061441-CC1473AC-7515-410F-8136-2C6F2C831A35Q35913566-1A80705E-9727-497A-B207-35534F4DD94BQ37598284-B9D9D356-B074-4EB3-ADB2-E84819025E7DQ37937746-4D98A67F-5AC1-4BAE-B0DB-080E35FA582BQ37977033-FF772A24-587B-4ED7-8EC7-057C01255BEDQ42910882-23A3F3F2-2CB2-4253-9E64-973FD3F3BC84Q43192045-58DD1214-CCA2-4472-832E-887B3AE19A75Q49122248-A2C60553-D3D9-42A9-8C6C-9FB5F35F5F1BQ55077604-20238D3F-73AA-4E4A-B624-129560B7DC45
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Chlorpromazine versus placebo for schizophrenia
@ast
Chlorpromazine versus placebo for schizophrenia
@en
Chlorpromazine versus placebo for schizophrenia
@en-gb
Chlorpromazine versus placebo for schizophrenia
@nl
type
label
Chlorpromazine versus placebo for schizophrenia
@ast
Chlorpromazine versus placebo for schizophrenia
@en
Chlorpromazine versus placebo for schizophrenia
@en-gb
Chlorpromazine versus placebo for schizophrenia
@nl
prefLabel
Chlorpromazine versus placebo for schizophrenia
@ast
Chlorpromazine versus placebo for schizophrenia
@en
Chlorpromazine versus placebo for schizophrenia
@en-gb
Chlorpromazine versus placebo for schizophrenia
@nl
P2093
P2860
P1476
Chlorpromazine versus placebo for schizophrenia
@en
P2093
Ben Thornley
George Awad
John Rathbone
P2860
P356
10.1002/14651858.CD000284.PUB2
P577
2007-04-18T00:00:00Z